SANUWAVE Health, Inc.

Sanuwave is a medical device enterprise specializing in directed energy solutions for regenerative medicine and wound care. The company focuses on noninvasive ultrasound technology designed to stimulate biological repair and tissue regeneration across musculoskeletal and vascular structures. Its primary commercial offering is the UltraMIST system, an FDA-cleared and patented platform that administers low-frequency, non-thermal ultrasound via a fluid mist without direct physical contact. The device treats acute and chronic wounds, including diabetic foot ulcers, surgical wounds, and deep tissue pressure injuries. Sanuwave supplies healthcare facilities, including hospitals, wound clinics, physician practices, nursing homes, and mobile wound care professionals.

Operating principally within the United States, the business distributes equipment and single-use applicators through direct representatives, independent distributors, and resellers. As of December 31, 2025, Sanuwave maintained 1,292 active systems across customer locations and employed 55 full-time personnel. The organization conducts operations from an FDA-registered, 20,019-square-foot facility providing administration, product development, quality control, and warehousing in Eden Prairie, Minnesota, where it is also headquartered.

Summary of the business section of SANUWAVE Health's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we had a total of 55 full time employees in the United States.”